基本信息
浏览量:75
职业迁徙
个人简介
Dr. Corcoran’s primary research interests include aerosol drug delivery and aerosol-based nuclear imaging of the lung. He has been extensively involved in the development of inhaled medications for lung transplant recipients and cystic fibrosis patients and the development special techniques for improving inhaled drug delivery such as the use of low density gases and surfactants to improve drug distribution in the lungs. Dr. Corcoran had developed imaging techniques for quantifying pulmonary physiology including measurements of mucociliary clearance and liquid absorption in the airways. These techniques have been tested in a series of clinical studies involving adult and pediatric patients and will be used to screen new medications for treating lung diseases such as cystic fibrosis. Dr. Corcoran is currently the Principal Investigator of two NIH RO1 grants. He has previously directed research funded by the U.S. Army and the Cystic Fibrosis Foundation.
研究兴趣
论文共 140 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Scott H. Donaldson,Timothy E. Corcoran,Joseph M. Pilewski,Beth L. Laube,Peter Mogayzel,Agathe Ceppe, Jihong Wu,Kirby Zeman,Steven M. Rowe,David P. Nichols,Alex H. Gifford,William D. Bennett, Nicole Mayer-Hamblett
Journal of cystic fibrosis (2024)
T.E. Corcoran, S.G. Kefalos, L. Weber,G. Kitsios,K. Hajipouran Benam,J. Bon,C.J. Kessinger,V. Petraglia, A. Morris
B80-1 METHODOLOGICAL ADVANCEMENTS IN PULMONARY IMAGING (2024)
Expert opinion on drug deliveryno. 8 (2024): 1175-1190
Frontiers in cellular and infection microbiology (2024)
THORAXno. 7 (2024): 597-598
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Societyno. 1 (2023): 155-160
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERYno. 6 (2023): A14-A14
引用0浏览0引用
0
0
加载更多
作者统计
#Papers: 140
#Citation: 2673
H-Index: 29
G-Index: 50
Sociability: 7
Diversity: 0
Activity: 1
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn